Previous Close | 85.46 |
Open | 86.20 |
Bid | 85.77 x N/A |
Ask | 86.08 x N/A |
Day's Range | 86.20 - 86.20 |
52 Week Range | 64.71 - 89.96 |
Volume | |
Avg. Volume | 1,087 |
Market Cap | 659.082B |
Beta (5Y Monthly) | 0.91 |
PE Ratio (TTM) | 40.47 |
EPS (TTM) | 2.13 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.60 (0.69%) |
Ex-Dividend Date | Mar 27, 2024 |
1y Target Est | N/A |
Agios Pharmaceuticals (AGIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Evaluate the expected performance of Stryker (SYK) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...